Hereditary Cancer Testing to Identify Disease Risk Launched
The Guardant Hereditary Cancer test is a blood-based genetic screening tool that identifies inherited cancer risk variants.
The Guardant Hereditary Cancer test is a blood-based genetic screening tool that identifies inherited cancer risk variants.
Revvity received FDA 510(k) clearance for EUROIMMUN’s automated immunoassay for direct quantitative measurement of free testosterone.
Werfen received CE mark for its Aptiva Antiphospholipid Syndrome IgG and IgM reagents under the EU's IVDR. Â
Absolute Biotech, a company uniting multiple antibody-centric brands into a single organization, is reintroducing SCICONS dsRNA antibodies.Â
Read MoreT2 Biosystems, Inc.,has submitted a 510(k) premarket notification to the FDA for the Company’s T2Biothreat Panel.
Read MoreU.S. Healthcare professionals can access a new novel NAD+ blood diagnostic test for their patients, following the new partnership.
Read MoreOncoHost, a diagnostics company centered on predictive biomarker development patient care, launched its non-small lung cancer (NSCLC) test.
Read MoreBeckman Coulter and MeMed are developing a diagnostic assay able to distinguish between bacterial and viral infections.
Read MoreBioSPME (Bioanalytical Solid Phase MicroExtraction), has been developed to provide a high throughput automatable cleaner sample
Read MoreThe liquid biopsy ctDx FIRST test is FDA approved as a companion diagnostic for advanced non-small cell lung cancer (NSCLC) patients.
Read MoreBD and CerTest Biotec have announced EUA from the U.S. Food and Drug Administration (FDA) for a molecular PCR assay for Mpox virus detection.
Read MoreClinical labs learned about the limitations of mpox testing during last summer’s outbreak, taking away valuable lessons.
Read MoreAmericans who are still in possession of COVID tests they acquired earlier in the year may wonder whether or not the tests have expired.
Read MoreThe FDA granted Emergency Use Authorization (EUA) for Thermo Fisher Scientific’s Applied Biosystems TaqPath Monkeypox/Orthopox Virus DNA Kit.
Read MorePerkinElmer has announced that the FDA has authorized the marketing of the EONIS SCID-SMA assay kit for the diagnosis of SMA and SCID.
Read MoreThe Native Antigen Company announced the launch of its latest SARS-CoV-2 antigens for the newly designated omicron BA.5 variant.
Read MoreFunding will bring Hologic’s Panther Fusion SARS-CoV-2/Flu A/B/RSV assay and Aptima SARS-CoV-2 assay in line with the FDA’s IVD standards.
Read MoreUS BioTek Laboratories is now offering Monkeypox Diagnostic Testing, utilizing a lesion swap specimen and RT-PCR testing.
Read More